Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|1|47-55

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.1, 2013-01, pp. : 47-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VDAC-Targeted Drugs Affecting Cytoprotection and Mitochondrial Physiology in Cerebrovascular and Cardiovascular Diseases

By  

Current Medicinal Chemistry, Vol. 24, Iss. 40, 2018-01 ,pp. : 4419-4434

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy in Cerebrovascular Diseases

By  

Current Gene Therapy, Vol. 7, Iss. 6, 2007-12 ,pp. : 421-433

Bentham Science Publishers

Access to resources Recommend Favorite

Apoptosis modulators in the therapy of neurodegenerative diseases

By Deigner H-P.   Haberkorn U.   Kinscherf R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 747-764

Informa Healthcare

Access to resources Recommend Favorite

Type 2 Transglutaminase in Neurodegenerative Diseases: The Mitochondrial Connection

By  

Current Pharmaceutical Design, Vol. 14, Iss. 3, 2008-01 ,pp. : 278-288

Bentham Science Publishers

Access to resources Recommend Favorite

Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 31, 2011-10 ,pp. : 3356-3373

Bentham Science Publishers

Access to resources Recommend Favorite